Research Hotspot and Application Status of Immune Evasion Mechanism in Ovarian Cancer

Ovarian cancer is one of the three major malignant tumors in gynecology, with increasing incidence and mortality rates. Currently, main treatment methods remain surgical intervention combination chemotherapy. However, due to its high recurrence rate risk drug resistance, overall prognosis poor. has been identified as an immunegenic tumor, recent years, continued advancement research into immune evasion mechanisms, immunotherapy emerged a groundbreaking modality. This article will focus on escape mechanisms their application ovarian cancer, providing comprehensive overview current status challenges it faces.